Stonekeep Investments’s AbbVie ABBV Stock Holding History

Stonekeep Investments’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$207K	Buy	+823	New	+$177K	0.12%	76

Other funds holding ABBV

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Stonekeep Investments's ABBV Position: Q2 2026 in Review

Stonekeep Investments opened a new position in AbbVie (ABBV) in Q2 2026: 823 shares worth $207K. The stake represents 0.12% of the portfolio and ranks #76 among its holdings.

2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Stonekeep Investments held 823 shares of AbbVie worth $207K as of Q2 2026.
AbbVie was a new Stonekeep Investments position in Q2 2026.
AbbVie made up 0.12% of Stonekeep Investments's portfolio in Q2 2026, its #76 holding.
2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Stonekeep Investments's 13F filing for Q2 2026, filed 10 Jul 2026.